Improved treatments in the last 10 years have pushed breast cancer death rates down by about 25 percent in the United States and Britain among young and middle-aged women, researchers said. Already 60,000 deaths have been avoided in the two countries because of the treatments, chemotherapy and tamoxifen, experts said.